References
- Benbadis SR. Tatum WO 4th Advances in the treatment of epilepsy. Am Fam Physician 2001;64:91-8
- Houtkooper MA, Lammertsma A, Meyer JW, Goedhart DM, Meinardi H, van Oorschot CA, et al. Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine? Epilepsia 1987;28:693-8 https://doi.org/10.1111/j.1528-1157.1987.tb03702.x
- Reinikainen KJ, Keranen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double-blind study. Epilepsy Res 1987;1:284-9 https://doi.org/10.1016/0920-1211(87)90003-9
- Rai PV. Clinical trial for the estimation of anticonvulsive properties and side reactions of a new drug ketocarbamazepine. 10th Epilepsy Int. Symp.; 1978 SEP 10-14; Vancouver. Brussels, Belgium and Connecticut, USA: International League Against Epilepsy, 1978
- Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate. Clin Pharmacokinet 1995;29:341-69 https://doi.org/10.2165/00003088-199529050-00004
- Gram L. Clinical experience with oxcarbazepine. Epilepsia 1994;35 Suppl 3:S21-2
- Baruzzi A, Albani F, Riva R. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. Epilepsia 1994;35:1419
- Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol 1994;271:301-8 https://doi.org/10.1016/0014-2999(94)90787-0
- Stefani A, Pisani A, De Murtas M, Mercuri NB, Marciani MG, Calabresi P. Action of GP47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents. Epilepsia 1995;36:997-1002 https://doi.org/10.1111/j.1528-1157.1995.tb00958.x
- Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-2
- Freidel M, Krause E, Kuhn K, Peper R, Vogel H. Oxcarbazepine in the treatment of epilepsy. Fortschr Neurol Psychiatr 2007;75:100-6 https://doi.org/10.1055/s-2006-932218
- Kothare SV, Khurana DS, Mostofi N, Melvin JJ, Marks HG, Valencia I, et al. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience. Pediatr Neurol 2006;35:235-9 https://doi.org/10.1016/j.pediatrneurol.2006.02.009
- Franzoni E, Garone C, Sarajlija J, Gualandi S, Malaspina E, Cecconi I, et al. Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report. Seizure 2006;15:292-8 https://doi.org/10.1016/j.seizure.2006.02.017
- Sachdeo R, Edward K, Hasegawa H. Safety and efficacyof oxcarbazepine 1200 mg/day in patients with recent onset partial epilepsy. Neurology 1999;52:391
- Schmidt D, Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 2000;1:396-405 https://doi.org/10.1006/ebeh.2000.0126
- Hooper WD, Dickinson RG, Dunstan PR, Pendlebury SC, Eadie MJ. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant. Clin Exp Neurol 1987;24:105-12
- Martinez W, Ingenito A, Blakeslee M, Barkley GL, McCague K, D'Souza J. Efficacy, safety, and tolerability of oxcarbazepine monotherapy. Epilepsy Behav 2006;9:448-56 https://doi.org/10.1016/j.yebeh.2006.04.022
- Rogvi-Hansen B, Gram L. Adverse effects of established and new antiepileptic drugs: an attempted comparison. Pharmacol Ther 1995;68:425-34 https://doi.org/10.1016/0163-7258(95)02014-4
- Horga JF, Horga A. Oxcarbazepine in the treatment of epilepsy. A review and update. Rev Neurol 2006;42:95-113
- Gilham RA, Williams N, Wiedmann K. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. J Neurol Neurosurg 1988;51:929-33 https://doi.org/10.1136/jnnp.51.7.929
- JG Larkin, PJ McKee, G Forrest, GH Beastall, BK Park, JI Lowrie, et al. Lack of enzyme induction with oxcarbazepine (600mg daily) in healthy subjects. Br J Clin Pharmacol 1991;31:657-1 https://doi.org/10.1002/j.1552-4604.1991.tb03752.x
- Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent. Clin Ther 2001;23:680-700 https://doi.org/10.1016/S0149-2918(01)80019-9
- Friis ML, Kristensen 0. Boas J, Dalby M, Deth SH, Gram L, et al. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol 1993;87:224-7
- Dam M, Ekberg R, Loyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients wtih newly, diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-6 https://doi.org/10.1016/0920-1211(89)90070-3
- Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia 1994;35:181-8 https://doi.org/10.1111/j.1528-1157.1994.tb02930.x
- Arieff AI, Ayus JC, Fraser CL. Hyponatraemia and deathor permanent brain damage in healthy children. Br Med J 1992;304:1218-22 https://doi.org/10.1136/bmj.304.6836.1218
- Steinhoff BJ, Stoll KD, Stodieck SR, Paulus W. Hyponatremic coma under oxcarbazepine therapy. Epilepsy Res 1992;11:67-70 https://doi.org/10.1016/0920-1211(92)90023-M
- Johannessen AC, Nielsen OA. Hyponatremia induced by oxcarbazepine. Epilepsy Res 1987;1155-6
- Kloster R, Borresen HC, Hoff-Olsen P. Sudden death in two patients with epilepsy and the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Seizure 1998;7:419-20 https://doi.org/10.1016/S1059-1311(05)80015-9
- Lee SA, Lee SK, Kang JK. Hyponatremia associated with oxcarbazepine: cross-sectional study. J Korean Neurol Assoc 2001;19:139-42
- Sachdeo RC, Wasserstein A, Mesenbrink PJ, D'Souza J. Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol 2002;51:613-20 https://doi.org/10.1002/ana.10190
- Dickinson RG, Hooper WD, Pendlebury SC, Moses D, Eadie MJ. Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine. Clin Exp Neurol 1988;25:127-33
- Nielsen OA, Johannessen AC, Bardrum B. Oxcarbazepine induced hyponatremia, a cross-sectional study. Epilepsy Res 1988;2:269-71 https://doi.org/10.1016/0920-1211(88)90018-6
- Holtmann M, Krause M, Opp J, Tokarzewski M, Korn-Merker E, Boenigk HE. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. Neuropediatrics 2002;33:298-300 https://doi.org/10.1055/s-2002-37081
- Wellington K, Goa KL. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs 2001;15:137-63 https://doi.org/10.2165/00023210-200115020-00005
- Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003;4:175-80 https://doi.org/10.1016/S1525-5050(03)00037-4
- Dong X, Leppik IE, White J, Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology 2005;65:1976-8 https://doi.org/10.1212/01.wnl.0000188819.45330.90
- Brewenton TD, Jackson CW. Prophylaxis of carbamezepineinduced hyponatremia by demeclocycline in six patients. J Clin Psychiatry 1994;55:249-51
- Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina 2004;40:935-42
- Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 1999;6:489-501
- Hitiris N, Brodie MJ. Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 2006;19:175-80
- Horga JF, Horga A. Oxcarbazepine in the treatment of epilepsy. A review and update. Rev Neurol 2006;42:95-113
- Mahmud J, Mathews M, Verma S, Basil B. Oxcarbazepine-induced thrombocytopenia. Psychosomatics 2006;47:73-4 https://doi.org/10.1176/appi.psy.47.1.73
- Calamaras MR, Stowe ZN, Newport DJ Pancytopenia associated with the introduction of oxcarbazepine. J Clin Psychopharmacol 2007;27:217-8 https://doi.org/10.1097/01.jcp.0000264971.92828.b2
- Beran RG. Cross-reactive skin eruption with both carbamazepine and oxcarbazepine. Epilepsia 1993;34:163-5 https://doi.org/10.1111/j.1528-1157.1993.tb02392.x
- Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007;48:1360-5 https://doi.org/10.1111/j.1528-1167.2007.01109.x
- Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007;68:1701-9 https://doi.org/10.1212/01.wnl.0000261917.83337.db
- Palmieri A. Oxcarbazepine-induced headache. Cephalalgia 2007;27:91-3 https://doi.org/10.1111/j.1468-2982.2007.01246.x
- Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y, et al. Oxcarbazepine Cognitive Study Group. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology 2006;67:679-82 https://doi.org/10.1212/01.wnl.0000230138.46508.5b
- Aikia M, Kalviainen R, Sivenius J, Halonen T, Riekkinen PJ. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992;11:199-203 https://doi.org/10.1016/0920-1211(92)90099-F
- Weintraub D, Buchsbaum R, Resor SR Jr, Hirsch LJ. Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy Behav 2007;10:105-10 https://doi.org/10.1016/j.yebeh.2006.08.008
- Besag FM. Behavioural effects of the newer antiepileptic drugs: an update. Expert Opin Drug Saf 2004;3:1-8 https://doi.org/10.1517/14740338.3.1.1
- Isojarvi JI, Pakarinen AJ, Rautio A, Pelkonen O, Myllyla VV. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Epilepsia 1994;35:1217-20 https://doi.org/10.1111/j.1528-1157.1994.tb01792.x
- Franzoni E, Marchiani V, Cecconi I, Moscano FC, Gualandi S, Garone C, et al. Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children. Eur J Neurol 2006;13:1389-91 https://doi.org/10.1111/j.1468-1331.2006.01535.x
- Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006;35:177-81 https://doi.org/10.1016/j.pediatrneurol.2006.03.004
- Kalis MM, Huff NA. Oxcarbazepine, an antiepileptic agent. Clin Ther 2001;23:680-700 https://doi.org/10.1016/S0149-2918(01)80019-9
- Knight AK, Cunningham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol 2005;12:560-1
- Walia KS, Khan EA, Ko DH, Raza SS, Khan YN. Side effects of antiepileptics:a review. Pain Pract 2004;4:194-203 https://doi.org/10.1111/j.1533-2500.2004.04304.x
- Lofgren E, Tapanainen JS, Koivunen R, Pakarinen A, Isojarvi JI. Oxcarbazepine and carbamazepine: expected and unexpected differences and similarities. Epilepsy Curr 2007;7:74-6 https://doi.org/10.1111/j.1535-7511.2007.00176.x
- Bulau P, Paar WD, von Unruh GE. Pharmacokintics of oxcarbazepine and lo-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 1988;34:311-3 https://doi.org/10.1007/BF00540963